Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

ABSTRACT:

SUBMITTER: Ramasamy MN 

PROVIDER: S-EPMC7674972 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature